Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 9
2004 6
2005 10
2006 12
2007 8
2008 17
2009 14
2010 12
2011 9
2012 7
2013 9
2014 9
2015 7
2016 2
2017 7
2018 3
2019 6
2020 6
2021 2
2022 2
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Aksoy YA, Xu B, Viswanathan K, Ahadi MS, Al Ghuzlan A, Alzumaili B, Bani MA, Barletta JA, Chau N, Chou A, Clarkson A, Clifton-Bligh RJ, De Leo A, Dogan S, Ganly I, Ghossein R, Gild ML, Glover AR, Hadoux J, Lamartina L, Lubin DJ, Magliocca K, Najdawi F, Nigam A, Papachristos A, Repaci A, Robinson BG, Sheen A, Shi Q, Sidhu SB, Sioson L, Solaroli E, Sywak MS, Tallini G, Tsang V, Turchini J, Untch BR, Gill AJ, Fuchs TL. Aksoy YA, et al. Among authors: robinson bg. Histopathology. 2024 May;84(6):947-959. doi: 10.1111/his.15141. Epub 2024 Jan 22. Histopathology. 2024. PMID: 38253940
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. Among authors: robinson bg. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma.
Chou A, Qiu MR, Crayton H, Wang B, Ahadi MS, Turchini J, Clarkson A, Sioson L, Sheen A, Singh N, Clifton-Bligh RJ, Robinson BG, Gild ML, Tsang V, Leong D, Sidhu SB, Sywak M, Delbridge L, Aniss A, Wright D, Graf N, Kumar A, Rathi V, Benitez-Aguirre P, Glover AR, Gill AJ. Chou A, et al. Among authors: robinson bg. Mod Pathol. 2023 Dec;36(12):100329. doi: 10.1016/j.modpat.2023.100329. Epub 2023 Sep 15. Mod Pathol. 2023. PMID: 37716505
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update.
Worrall BJ, Papachristos A, Aniss A, Glover A, Sidhu SB, Clifton-Bligh RJ, Learoyd D, Tsang VHM, Gild M, Robinson BG, Sywak MS. Worrall BJ, et al. Among authors: robinson bg. Endocr Oncol. 2023 Mar 13;3(1):e220095. doi: 10.1530/EO-22-0095. eCollection 2023 Jan 1. Endocr Oncol. 2023. PMID: 37434647 Free PMC article.
Medullary Thyroid Cancer: Updates and Challenges.
Gild ML, Clifton-Bligh RJ, Wirth LJ, Robinson BG. Gild ML, et al. Among authors: robinson bg. Endocr Rev. 2023 Sep 15;44(5):934-946. doi: 10.1210/endrev/bnad013. Endocr Rev. 2023. PMID: 37204852 Free PMC article.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Brose MS, Robinson BG, Sherman SI, Jarzab B, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Sen S, Oliver JW, Banerjee K, Keam B, Capdevila J. Brose MS, et al. Among authors: robinson bg. Cancer. 2022 Dec 15;128(24):4203-4212. doi: 10.1002/cncr.34493. Epub 2022 Oct 19. Cancer. 2022. PMID: 36259380 Free PMC article. Clinical Trial.
149 results